Physician profile
Roxann V Clarke
NPI 1174829923
$4,359.77
in general payments reported to CMS, 2019-2025
17 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what 92% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $800 · 2021: $590 · 2022: $220 · 2023: $315 · 2024: $588 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,708 · Travel and Lodging: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,708.47 |
| Travel and Lodging | $830.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,666.34 | 2020-2025 | Prostep, Ortholoc 3di, Augment Injectable |
| Averitas Pharma INC. | $697.69 | 2023-2025 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $248.63 | 2020-2024 | Jublia, Bryhali |
| Paratek Pharmaceuticals, INC. | $200.04 | 2021-2023 | Nuzyra |
| Smith+Nephew, INC. | $179.90 | 2021-2022 | |
| Orthofix Medical, INC. | $168.14 | 2020-2022 | |
| Grt US Holding, INC. | $154.87 | 2025 | Qutenza |
| Alafair Biosciences, INC. | $150.00 | 2023 | Versawrap |
| Kci USA, INC. | $145.81 | 2020 | |
| Wright Medical Technology, INC. | $138.99 | 2020 | |
| Horizon Therapeutics Plc | $135.62 | 2019-2021 | |
| Pfizer INC. | $132.49 | 2019 | |
| Djo, LLC | $124.69 | 2025 | Cmf |
| Abbott Laboratories | $102.72 | 2020 | |
| Sebela Pharmaceuticals INC. | $52.61 | 2020-2023 | Pramosone, Naftin |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $46.90 | 2019 | |
| Bioventus LLC | $14.33 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxann Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.